- Home
- / Diplomat Pharmacy
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Diplomat Pharmacy financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
$5.5 B
FY, 2018
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 |
|---|---|---|---|---|---|
| Revenue | 2.2B | 3.4B | 4.4B | 4.5B | 5.5B |
| Revenue growth, % | 52.0% | 31.0% | |||
| Cost of goods sold | 2.1B | 3.1B | 4.1B | 4.1B | 5.1B |
| Gross profit | 140.1M | 263.2M | 324.8M | 348.7M | 376.0M |
| Gross profit margin, % | 6.3% | 7.8% | 7.4% | 7.8% | 6.8% |
| Operating expense total | 127.6M | 217.3M | 277.8M | 330.1M | 643.3M |
| EBIT | 12.6M | 45.9M | 47.1M | 18.6M | (267.3M) |
| EBIT margin, % | 0.6% | 1.4% | 1.1% | 0.4% | -4.9% |
| Investment income | (6.2M) | (4.7M) | (329.0K) | ||
| Interest income | 1.1M | 308.0K | 370.0K | 213.0K | 2.0M |
| Interest expense | 3.4M | 4.9M | 10.9M | 10.5M | 40.0M |
| Pre tax profit | 9.2M | 41.0M | 36.2M | 8.1M | (307.3M) |
| Income tax expense | (4.7M) | 16.2M | 11.2M | (7.1M) | (5.0M) |
| Net Income | 4.8M | 25.8M | 28.3M | 15.5M | (302.3M) |